Essential thrombocytosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
{{SK}} Essential thrombocythemia, primary thrombocythemia, inherited essential thrombocythemia, inherited Essential thrombocytosis, inherited essential thrombocythemia, inherited ET, congenital essential thrombocytosis, congenital essential thrombocythaemia, congenital essential thrombocythemia, congenital ET, hereditary essential thrombocytosis, hereditary essential thrombocythaemia, hereditary essential thrombocythemia, hereditary ET, familial essential thrombocythemia, familial essential thrombocytosis, familial essential thrombocythaemia, familial ET, Epstein-Goedel syndrome | {{SK}} Essential thrombocythemia, primary thrombocythemia, inherited essential thrombocythemia, inherited Essential thrombocytosis, inherited essential thrombocythemia, inherited ET, congenital essential thrombocytosis, congenital essential thrombocythaemia, congenital essential thrombocythemia, congenital ET, hereditary essential thrombocytosis, hereditary essential thrombocythaemia, hereditary essential thrombocythemia, hereditary ET, familial essential thrombocythemia, familial essential thrombocytosis, familial essential thrombocythaemia, familial ET, Epstein-Goedel syndrome | ||
==[[Essential thrombocytosis overview|Overview]]=='''Essential thrombocytosis''' '''(ET)''' is a rare hematologic disorder characterized by overproduction of platelets in the absence of an underlying disease.Platelets are responsible for hemostasis that is to control bleeding by forming plugs at the site of injury. | ==[[Essential thrombocytosis overview|Overview]]=='''Essential thrombocytosis''' '''(ET)''' is a rare hematologic disorder characterized by overproduction of platelets in the absence of an underlying disease.Platelets are responsible for hemostasis that is to control bleeding by forming plugs at the site of injury. Though overproduced, the platelets in ET are usually dysfunctional resulting in the vascular complications. | ||
==[[Essential thrombocytosis historical perspective|Historical Perspective]]== | ==[[Essential thrombocytosis historical perspective|Historical Perspective]]== | ||
The disease, also called as Epstein-Goedel syndrome was first described by pathologists Emil Epstein and Alfred Goedel in the year 1934. | The disease, also called as Epstein-Goedel syndrome was first described by pathologists Emil Epstein and Alfred Goedel in the year 1934. | ||
Revision as of 18:55, 28 October 2015
For patient information, click here
Template:DiseaseDisorder infobox
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis |
|
Risk calculators and risk factors for Essential thrombocytosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Essential thrombocythemia, primary thrombocythemia, inherited essential thrombocythemia, inherited Essential thrombocytosis, inherited essential thrombocythemia, inherited ET, congenital essential thrombocytosis, congenital essential thrombocythaemia, congenital essential thrombocythemia, congenital ET, hereditary essential thrombocytosis, hereditary essential thrombocythaemia, hereditary essential thrombocythemia, hereditary ET, familial essential thrombocythemia, familial essential thrombocytosis, familial essential thrombocythaemia, familial ET, Epstein-Goedel syndrome
==Overview==Essential thrombocytosis (ET) is a rare hematologic disorder characterized by overproduction of platelets in the absence of an underlying disease.Platelets are responsible for hemostasis that is to control bleeding by forming plugs at the site of injury. Though overproduced, the platelets in ET are usually dysfunctional resulting in the vascular complications.
Historical Perspective
The disease, also called as Epstein-Goedel syndrome was first described by pathologists Emil Epstein and Alfred Goedel in the year 1934.
Classification
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes
Differentiating Essential thrombocytosis from other Diseases
Natural History, Complications & Prognosis
Diagnosis
History & Symptoms | Physical Examination | Staging | Lab Tests | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Diagnostic criteria
Treatment
Medical Therapy | Special care related to pregnancy | Surgery | Primary Prevention | Secondary Prevention
Resources
- Cancerbackup Essential Thrombocytosis page
- CMPD Education Foundation
- MPD Foundation and Research Alliance - Register for a free newsletter
- Overview of Agrylin, the tradename for anagrelide hydrochloride